| __timestamp | Amphastar Pharmaceuticals, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 210461000 | 28203205 |
| Thursday, January 1, 2015 | 251519000 | 99892000 |
| Friday, January 1, 2016 | 255165000 | 133591000 |
| Sunday, January 1, 2017 | 240175000 | 154937000 |
| Monday, January 1, 2018 | 294666000 | 164246000 |
| Tuesday, January 1, 2019 | 322357000 | 175338000 |
| Wednesday, January 1, 2020 | 349846000 | 198321000 |
| Friday, January 1, 2021 | 437768000 | 227490000 |
| Saturday, January 1, 2022 | 498987000 | 212018000 |
| Sunday, January 1, 2023 | 644395000 | 145238000 |
Cracking the code
In the competitive landscape of pharmaceuticals, revenue growth is a key indicator of success. Over the past decade, Amphastar Pharmaceuticals, Inc. has consistently outperformed Travere Therapeutics, Inc. in annual revenue. Starting in 2014, Amphastar's revenue was nearly 7.5 times that of Travere's. By 2023, Amphastar's revenue surged by over 200%, reaching a peak that is more than four times Travere's earnings.
Amphastar's revenue trajectory shows a steady climb, with a notable 30% increase from 2021 to 2023. In contrast, Travere's revenue peaked in 2021 but saw a decline by 2023. This trend highlights Amphastar's robust market strategy and adaptability in a dynamic industry.
As we look to the future, Amphastar's consistent growth positions it as a leader in the pharmaceutical sector, while Travere may need to innovate to close the revenue gap.
Revenue Insights: Pfizer Inc. and Amphastar Pharmaceuticals, Inc. Performance Compared
Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.: Examining Key Revenue Metrics
GSK plc vs Amphastar Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Bio-Techne Corporation vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Walgreens Boots Alliance, Inc. and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Exelixis, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
TG Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
PTC Therapeutics, Inc. vs Travere Therapeutics, Inc.: Annual Revenue Growth Compared
Revenue Showdown: Veracyte, Inc. vs Travere Therapeutics, Inc.
Comparing Revenue Performance: Merus N.V. or Travere Therapeutics, Inc.?
Who Generates More Revenue? HUTCHMED (China) Limited or Travere Therapeutics, Inc.
Annual Revenue Comparison: ImmunityBio, Inc. vs Travere Therapeutics, Inc.